Stock Events

Stock Events

Oncolys BioPharma (4588.TSE) Q2 2024 Earnings

10MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-19

-18

-18

-18

Details

Expected EPS

N/A

Actual EPS

-19

Surprise EPS

-19

Surprise Percent

+∞%

Description

Oncolys BioPharma (4588.TSE) has reported earnings of -19 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.